United Bank (Virginia)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,369
Closed -$212K 155
2018
Q3
$212K Buy
+2,369
New +$209K 0.04% 132
2018
Q2
Sell
-5,742
Closed -$512K 133
2018
Q1
$512K Sell
5,742
-277
-5% -$26.6K 0.12% 74
2017
Q4
$628K Buy
6,019
+3,171
+111% +$358K 0.15% 77
2017
Q3
$415K Sell
2,848
-202
-7% -$27.5K 0.4% 35
2017
Q2
$396K Buy
3,050
+202
+7% +$24.8K 0.39% 36
2017
Q1
$354K Hold
2,848
0.36% 37
2016
Q4
$330K Sell
2,848
-420
-13% -$46.8K 0.4% 40
2016
Q3
$342K Hold
3,268
0.37% 44
2016
Q2
$322K Hold
3,268
0.32% 45
2016
Q1
$327K Hold
3,268
0.33% 46
2015
Q4
$391K Hold
3,268
0.47% 40
2015
Q3
$353K Buy
+3,268
New +$406K 0.48% 40

Other funds holding CELG

United Bank (Virginia)'s CELG Position: Q4 2018 in Review

United Bank (Virginia) sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,369 shares — an estimated $212K sold.

United Bank (Virginia) first reported a position in CELG in Q3 2015 and held it in 12 quarters. The position peaked at $628K in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • United Bank (Virginia) reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • United Bank (Virginia) sold 2,369 Celgene Corp shares in Q4 2018, an estimated $212K.
  • United Bank (Virginia) first reported a position in Celgene Corp in Q3 2015 and held it in 12 quarters.
  • United Bank (Virginia)'s Celgene Corp position peaked at $628K in Q4 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on United Bank (Virginia)'s 13F filing for Q4 2018, filed 14 Feb 2019.